Smart Patients Get Smart Care™

The World’s Leading Authority for Chronic Lymphocytic Leukemia Patients

Search Results for: Zanubrutinib

Zanubrutinib

Zanubrutinib may be taken alone as a preferred initial (first-line) treatment, or alone as a second- or third-line treatment.

Didn't find what you where looking for?

Try our advanced search page!